Search Results - D. I. Rudenko
- Showing 1 - 7 results of 7
-
1
Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies by V. M. Suslov, D. I. Rudenko
Published 2024-11-01The author presents a literature review on the safety and efficacy of antisense oligonucleotides in the treatment of Duchenne muscular dystrophy using the exon skipping method using Viltepso® (viltolarsen), the only drug of this class registered in Russia, as an example. The analysis of internationa...
Get full text
Article -
2
Dynamics of the course of Duchenne muscular dystrophy in patients taking ataluren and concomitant drug and non-drug therapy by V. M. Suslov, L. N. Liberman, D. I. Rudenko, G. A. Suslova
Published 2024-01-01Background. Duchenne muscular dystrophy is a hereditary, X-linked, progressive, disabling disease. One of the possible pathogenetic methods for treating this disease is the drug ataluren, which acts at the stage of protein translation in the ribosome and makes it possible to read information from mR...
Get full text
Article -
3
Analysis of clinical manifestations and diagnosis of late-onset myasthenia gravis by A. N. Khalmurzina, T. M. Alekseeva, S. V. Lobzin, D. I. Rudenko, V. V. Kryuchkova
Published 2020-06-01Introduction. Myasthenia gravis is one of the most common autoimmune neuromuscular diseases, the peak incidence is in the age of 20–40 years. However, studies show that throughout the world in recent decades there has been an increase in the prevalence and incidence of myasthenia gravis among older...
Get full text
Article -
4
Optimization of the pre-analytical stage of material processing for histochemical examination of skeletal muscle biopsies in the diagnosis of neuromuscular diseases by A. M. Sycheva, V. D. Nazarova, S. V. Lapin, M. G. Rybakova, D. I. Rudenko
Published 2019-07-01Diagnosis of neuromuscular diseases is complicated by the variety of clinical manifestations and requires the use of additional methods, an important place among which is the pathomorphological study of skeletal muscle biopsy. Despite the fact that the procedure for taking a muscle biopsy is not tec...
Get full text
Article -
5
HIRAYAMA DISEASE. CLINICAL CASE AND A REVIEW OF LITERATURE by E. R. Barantsevich, D. I. Rudenko, O. V. Posokhina, A. A. Yakovlev, R. A. Gapeshin, A. G. Smochilin, E. O. Scherbakova
Published 2017-03-01Hirayama disease is a rare neurological disease with unilateral or asymmetric bilateral distal upper limb paresis and muscle atrophy. Here the authors report a clinical case of patient with weakness of cluster muscles and distal asymmetric upper paraparesis. Taking into consideration complaints, cl...
Get full text
Article -
6
Features of psychological adaptation and compensatory mechanisms in patients with severe chronic diseases by V. Yu. Kudryashova, N. B. Lutova, D. I. Rudenko, A. Ya. Vuks, T. R. Stuchevskaya, O. D. Egorova, N. K. Kulagina, S. M. Zatakovenko
Published 2020-12-01The aim of the study was self-regulation of behavior and other psychological aspects of adaptive-compensatory mechanisms in patients with schizophrenia and myasthenia, in comparison with a group of healthy subjects.Materials and methods. The study involved 91 people: patients with schizophrenia (N=3...
Get full text
Article -
7
Clinical and diagnostic difficulties in management of patients with laminopathies by O. V. Melnik, A. B. Malashicheva, Yu. V. Fomicheva, A. A. Khudyakov, A. Ya. Gudkova, D. I. Rudenko, M. A. Simonenko, Е. N. Mikhailov, D. S. Lebedev, E. S. Vasichkina, T. M. Pervunina, A. A. Kostareva
Published 2019-11-01Mutations in the LMNA gene cause developing of several phenotypes, both with isolated involvement of cardiac, muscle, adipose and bone tissues, and with their combination. The dominance of cardiovascular signs in the clinical performance and false clarity in nosology definition can cause underestima...
Get full text
Article